Startups
Typewriter Therapeutics
Develops genetic medicines using an RNA-based platform that inserts whole therapeutic genes at a specific genomic site without viral vectors or double-strand DNA breaks. It uses lipid nanoparticles to deliver RNA, with programs for in vivo CAR-T cell engineering and liver-directed gene insertion targeting cancer, autoimmune disease and severe genetic disorders.
Founded 2022